Carrie L. Bourdow - 01 Aug 2022 Form 4 Insider Report for Nabriva Therapeutics plc

Role
Director
Signature
/s/ J. Christopher Naftzger, by power of attorney
Issuer symbol
N/A
Transactions as of
01 Aug 2022
Net transactions value
-$1,487
Form type
4
Filing time
03 Aug 2022, 21:47:54 UTC
Previous filing
24 Jun 2022
Next filing
06 Dec 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRV Ordinary Shares Sale $1,487 -8,540 -46% $0.1741* 9,933 01 Aug 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.